수의학적 신장병 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2032년)

The global demand for Veterinary Renal Disease Market is presumed to reach the market size of nearly USD 28.53 Billion by 2032 from USD 16.23 Billion in 2023 with a CAGR of 6.47% under the study period 2024 - 2032.

Veterinary Renal Disease refers to kidney-related health issues in animals. This encompasses conditions impacting the structure and functionality of kidneys in both pets and livestock, accompanied by diagnostic and treatment approaches customized to meet the unique requirements of animals.

MARKET DYNAMICS

The veterinary renal disease market is primarily driven by the growing pet population and an increasing focus on animal healthcare. The rise in pet adoption, heightened awareness of veterinary care, and advancements in diagnostic technologies contribute to the market's expansion. The prevalence of renal diseases in animals, particularly in aging pets, underscores the demand for effective diagnostic and therapeutic solutions. Additionally, pet owners' willingness to invest in specialized veterinary services and treatments for their animals further propels market growth. The veterinary industry's continuous efforts in research and development for innovative renal disease management solutions also shape the market landscape.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of veterinary renal disease. The growth and trends of veterinary renal disease industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the veterinary renal disease market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

• Diagnosis (Test Kits & Consumables, Instruments)
• Treatment(Drugs (Nsaids, Antibiotics, Cystine-Binding Agents, Diuretics, Others), Therapeutic Food Supplements, Ringer Lactate Solution)

By Animal Type

• Canine
• Feline
• Bovine
• Equine
• Others

By Route Of Administration

• Oral
• Injectable

By Indication

• Renal Failure
• Chronic Kidney Disease (CKD)
• Renal Cystitis
• Kidney Stones
• Nephritis
• Others

By Distribution Channel

• Veterinary Hospitals & Clinics
• Pet Specialty Stores
• E-Commerce
• Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Veterinary Renal Disease market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Veterinary Renal Disease market include Mars Inc., Nestle Purina PetCare, Hills Pet Nutrition, J.M.Smucker, General Mills, Zoetis Inc., Merck & Co., Inc., Elanco, Phibro Animal Health Corporation, Ceva Sante Animale, Boehringer Ingelheim Animal Health, Dechra Pharmaceuticals, VetPharma, Vedco Inc., Mission Pharmacal Company, Rayne Clinical Nutrition, Neogen Corporation, Roquette Freres. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . VETERINARY RENAL DISEASE - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Type
  • 3.7.2 Market Attractiveness Analysis By Animal Type
  • 3.7.3 Market Attractiveness Analysis By Route of Administration
  • 3.7.4 Market Attractiveness Analysis By Indication
  • 3.7.5 Market Attractiveness Analysis By Distribution Channel
  • 3.7.6 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL VETERINARY RENAL DISEASE MARKET ANALYSIS BY TYPE

• 5.1 Overview by Type
• 5.2 Historical and Forecast Data
• 5.3 Analysis by Type
• 5.4 Diagnosis (Test Kits & Consumables, Instruments) Historic and Forecast Sales by Regions
• 5.5 Treatment(Drugs (NSAIDs, Antibiotics, Cystine-binding Agents, Diuretics, Others), Therapeutic Food Supplements, Ringer Lactate Solution) Historic and Forecast Sales by Regions

6 . GLOBAL VETERINARY RENAL DISEASE MARKET ANALYSIS BY ANIMAL TYPE

• 6.1 Overview by Animal Type
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Animal Type
• 6.4 Canine Historic and Forecast Sales by Regions
• 6.5 Feline Historic and Forecast Sales by Regions
• 6.6 Bovine Historic and Forecast Sales by Regions
• 6.7 Equine Historic and Forecast Sales by Regions
• 6.8 Others Historic and Forecast Sales by Regions

7 . GLOBAL VETERINARY RENAL DISEASE MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

• 7.1 Overview by Route of Administration
• 7.2 Historical and Forecast Data
• 7.3 Analysis by Route of Administration
• 7.4 Oral Historic and Forecast Sales by Regions
• 7.5 Injectable Historic and Forecast Sales by Regions

8 . GLOBAL VETERINARY RENAL DISEASE MARKET ANALYSIS BY INDICATION

• 8.1 Overview by Indication
• 8.2 Historical and Forecast Data
• 8.3 Analysis by Indication
• 8.4 Renal Failure Historic and Forecast Sales by Regions
• 8.5 Chronic Kidney Disease (CKD) Historic and Forecast Sales by Regions
• 8.6 Renal Cystitis Historic and Forecast Sales by Regions
• 8.7 Kidney Stones Historic and Forecast Sales by Regions
• 8.8 Nephritis Historic and Forecast Sales by Regions
• 8.9 Others Historic and Forecast Sales by Regions

9 . GLOBAL VETERINARY RENAL DISEASE MARKET ANALYSIS BY DISTRIBUTION CHANNEL

• 9.1 Overview by Distribution Channel
• 9.2 Historical and Forecast Data
• 9.3 Analysis by Distribution Channel
• 9.4 Veterinary Hospitals & Clinics Historic and Forecast Sales by Regions
• 9.5 Pet Specialty Stores Historic and Forecast Sales by Regions
• 9.6 E-Commerce Historic and Forecast Sales by Regions
• 9.7 Others Historic and Forecast Sales by Regions

10 . GLOBAL VETERINARY RENAL DISEASE MARKET ANALYSIS BY GEOGRAPHY

• 10.1. Regional Outlook
• 10.2. Introduction
• 10.3. North America Sales Analysis
  • 10.3.1. Overview, Historic and Forecast Data Sales Analysis
  • 10.3.2. North America By Segment Sales Analysis
  • 10.3.3. North America By Country Sales Analysis
  • 10.3.4. United State Sales Analysis
  • 10.3.5. Canada Sales Analysis
  • 10.3.6. Mexico Sales Analysis
• 10.4. Europe Sales Analysis
  • 10.4.1. Overview, Historic and Forecast Data Sales Analysis
  • 10.4.2. Europe by Segment Sales Analysis
  • 10.4.3. Europe by Country Sales Analysis
  • 10.4.4. United Kingdom Sales Analysis
  • 10.4.5. France Sales Analysis
  • 10.4.6. Germany Sales Analysis
  • 10.4.7. Italy Sales Analysis
  • 10.4.8. Russia Sales Analysis
  • 10.4.9. Rest Of Europe Sales Analysis
• 10.5. Asia Pacific Sales Analysis
  • 10.5.1. Overview, Historic and Forecast Data Sales Analysis
  • 10.5.2. Asia Pacific by Segment Sales Analysis
  • 10.5.3. Asia Pacific by Country Sales Analysis
  • 10.5.4. China Sales Analysis
  • 10.5.5. India Sales Analysis
  • 10.5.6. Japan Sales Analysis
  • 10.5.7. South Korea Sales Analysis
  • 10.5.8. Australia Sales Analysis
  • 10.5.9. South East Asia Sales Analysis
  • 10.5.10. Rest Of Asia Pacific Sales Analysis
• 10.6. Latin America Sales Analysis
  • 10.6.1. Overview, Historic and Forecast Data Sales Analysis
  • 10.6.2. Latin America by Segment Sales Analysis
  • 10.6.3. Latin America by Country Sales Analysis
  • 10.6.4. Brazil Sales Analysis
  • 10.6.5. Argentina Sales Analysis
  • 10.6.6. Peru Sales Analysis
  • 10.6.7. Chile Sales Analysis
  • 10.6.8. Rest of Latin America Sales Analysis
• 10.7. Middle East & Africa Sales Analysis
  • 10.7.1. Overview, Historic and Forecast Data Sales Analysis
  • 10.7.2. Middle East & Africa by Segment Sales Analysis
  • 10.7.3. Middle East & Africa by Country Sales Analysis
  • 10.7.4. Saudi Arabia Sales Analysis
  • 10.7.5. UAE Sales Analysis
  • 10.7.6. Israel Sales Analysis
  • 10.7.7. South Africa Sales Analysis
  • 10.7.8. Rest Of Middle East And Africa Sales Analysis

11 . COMPETITIVE LANDSCAPE OF THE VETERINARY RENAL DISEASE COMPANIES

• 11.1. Veterinary Renal Disease Market Competition
• 11.2. Partnership/Collaboration/Agreement
• 11.3. Merger And Acquisitions
• 11.4. New Product Launch
• 11.5. Other Developments

12 . COMPANY PROFILES OF VETERINARY RENAL DISEASE INDUSTRY

• 12.1. Company Share Analysis
• 12.2. Market Concentration Rate
• 12.3. Mars Inc.
  • 12.3.1. Company Overview
  • 12.3.2. Company Revenue
  • 12.3.3. Products
  • 12.3.4. Recent Developments
• 12.4. Nestle Purina PetCare
  • 12.4.1. Company Overview
  • 12.4.2. Company Revenue
  • 12.4.3. Products
  • 12.4.4. Recent Developments
• 12.5. Hills Pet Nutrition
  • 12.5.1. Company Overview
  • 12.5.2. Company Revenue
  • 12.5.3. Products
  • 12.5.4. Recent Developments
• 12.6. J.M.Smucker
  • 12.6.1. Company Overview
  • 12.6.2. Company Revenue
  • 12.6.3. Products
  • 12.6.4. Recent Developments
• 12.7. General Mills
  • 12.7.1. Company Overview
  • 12.7.2. Company Revenue
  • 12.7.3. Products
  • 12.7.4. Recent Developments
• 12.8. Zoetis Inc.
  • 12.8.1. Company Overview
  • 12.8.2. Company Revenue
  • 12.8.3. Products
  • 12.8.4. Recent Developments
• 12.9. Merck & Co. Inc.
  • 12.9.1. Company Overview
  • 12.9.2. Company Revenue
  • 12.9.3. Products
  • 12.9.4. Recent Developments
• 12.10. Elanco
  • 12.10.1. Company Overview
  • 12.10.2. Company Revenue
  • 12.10.3. Products
  • 12.10.4. Recent Developments
• 12.11. Phibro Animal Health Corporation
  • 12.11.1. Company Overview
  • 12.11.2. Company Revenue
  • 12.11.3. Products
  • 12.11.4. Recent Developments
• 12.12. Ceva Sante Animale
  • 12.12.1. Company Overview
  • 12.12.2. Company Revenue
  • 12.12.3. Products
  • 12.12.4. Recent Developments
• 12.13. Boehringer Ingelheim Animal Health
  • 12.13.1. Company Overview
  • 12.13.2. Company Revenue
  • 12.13.3. Products
  • 12.13.4. Recent Developments
• 12.14. Dechra Pharmaceuticals
  • 12.14.1. Company Overview
  • 12.14.2. Company Revenue
  • 12.14.3. Products
  • 12.14.4. Recent Developments
• 12.15. VetPharma
  • 12.15.1. Company Overview
  • 12.15.2. Company Revenue
  • 12.15.3. Products
  • 12.15.4. Recent Developments
• 12.16. Vedco Inc.
  • 12.16.1. Company Overview
  • 12.16.2. Company Revenue
  • 12.16.3. Products
  • 12.16.4. Recent Developments
• 12.17. Mission Pharmacal Company
  • 12.17.1. Company Overview
  • 12.17.2. Company Revenue
  • 12.17.3. Products
  • 12.17.4. Recent Developments
• 12.18. Rayne Clinical Nutrition
  • 12.18.1. Company Overview
  • 12.18.2. Company Revenue
  • 12.18.3. Products
  • 12.18.4. Recent Developments
• 12.19. Neogen Corporation
  • 12.19.1. Company Overview
  • 12.19.2. Company Revenue
  • 12.19.3. Products
  • 12.19.4. Recent Developments
• 12.20. Roquette Freres
  • 12.20.1. Company Overview
  • 12.20.2. Company Revenue
  • 12.20.3. Products
  • 12.20.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies